Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 45

1.

Performance measures among non-immigrants and immigrants attending BreastScreen Norway: a population-based screening programme.

Bhargava S, Akslen LA, Bukholm IRK, Hofvind S.

Eur Radiol. 2019 Sep;29(9):4833-4842. doi: 10.1007/s00330-019-6009-2. Epub 2019 Feb 14.

PMID:
30762109
2.

Somatic EP300-G211S mutations are associated with overall somatic mutational patterns and breast cancer specific survival in triple-negative breast cancer.

Bemanian V, Noone JC, Sauer T, Touma J, Vetvik K, Søderberg-Naucler C, Lindstrøm JC, Bukholm IR, Kristensen VN, Geisler J.

Breast Cancer Res Treat. 2018 Nov;172(2):339-351. doi: 10.1007/s10549-018-4927-3. Epub 2018 Aug 21.

PMID:
30132219
3.

In breast cancer subtypes steroid sulfatase (STS) is associated with less aggressive tumour characteristics.

McNamara KM, Guestini F, Sauer T, Touma J, Bukholm IR, Lindstrøm JC, Sasano H, Geisler J.

Br J Cancer. 2018 May;118(9):1208-1216. doi: 10.1038/s41416-018-0034-9. Epub 2018 Mar 22.

4.

Compensation after treatment for anterior cruciate ligament injuries: a review of compensation claims in Norway from 2005 to 2015.

Randsborg PH, Bukholm IRK, Jakobsen RB.

Knee Surg Sports Traumatol Arthrosc. 2018 Feb;26(2):628-633. doi: 10.1007/s00167-017-4809-y. Epub 2017 Nov 27.

5.

Low Expression of Estrogen Receptor-α and Progesterone Receptor in Human Breast Cancer Tissues Is Associated With High-Grade Human Cytomegalovirus Protein Expression.

Rahbar A, Touma J, Costa H, Davoudi B, Bukholm IR, Sauer T, Vetvik K, Geisler J, Söderberg-Naucler C.

Clin Breast Cancer. 2017 Nov;17(7):526-535.e1. doi: 10.1016/j.clbc.2017.04.013. Epub 2017 May 11.

PMID:
28595965
6.

Claims for compensation after injuries related to airway management: a nationwide study covering 15 years.

Fornebo I, Simonsen KA, Bukholm IRK, Kongsgaard UE.

Acta Anaesthesiol Scand. 2017 Aug;61(7):781-789. doi: 10.1111/aas.12914. Epub 2017 May 30.

PMID:
28556897
7.

Integrative clustering reveals a novel split in the luminal A subtype of breast cancer with impact on outcome.

Aure MR, Vitelli V, Jernström S, Kumar S, Krohn M, Due EU, Haukaas TH, Leivonen SK, Vollan HK, Lüders T, Rødland E, Vaske CJ, Zhao W, Møller EK, Nord S, Giskeødegård GF, Bathen TF, Caldas C, Tramm T, Alsner J, Overgaard J, Geisler J, Bukholm IR, Naume B, Schlichting E, Sauer T, Mills GB, Kåresen R, Mælandsmo GM, Lingjærde OC, Frigessi A, Kristensen VN, Børresen-Dale AL, Sahlberg KK; OSBREAC.

Breast Cancer Res. 2017 Mar 29;19(1):44. doi: 10.1186/s13058-017-0812-y.

8.

Complaints to the Norwegian System of Patient Injury Compensation 2001-14 following nerve blockade.

Kongsgaard UE, Fischer K, Pedersen TE, Bukholm IR, Warncke T.

Tidsskr Nor Laegeforen. 2016 Dec 20;136(23-24):1989-1992. doi: 10.4045/tidsskr.16.0368. eCollection 2016 Dec. English, Norwegian.

9.

Pathology-related cases in the Norwegian System of Patient Injury Compensation in the period 2010-2015.

Alfsen GC, Chen Y, Kähler H, Bukholm IR.

Tidsskr Nor Laegeforen. 2016 Dec 20;136(23-24):1984-1987. doi: 10.4045/tidsskr.16.0435. eCollection 2016 Dec. English, Norwegian.

10.

Subtype-specific micro-RNA expression signatures in breast cancer progression.

Haakensen VD, Nygaard V, Greger L, Aure MR, Fromm B, Bukholm IR, Lüders T, Chin SF, Git A, Caldas C, Kristensen VN, Brazma A, Børresen-Dale AL, Hovig E, Helland Å.

Int J Cancer. 2016 Sep 1;139(5):1117-28. doi: 10.1002/ijc.30142. Epub 2016 May 9.

11.

GFRA3 promoter methylation may be associated with decreased postoperative survival in gastric cancer.

Eftang LL, Klajic J, Kristensen VN, Tost J, Esbensen QY, Blom GP, Bukholm IR, Bukholm G.

BMC Cancer. 2016 Mar 16;16:225. doi: 10.1186/s12885-016-2247-8.

12.

Gene expression analysis supports tumor threshold over 2.0 cm for T-category breast cancer.

Solvang HK, Frigessi A, Kaveh F, Riis ML, Lüders T, Bukholm IR, Kristensen VN, Andreassen BK.

EURASIP J Bioinform Syst Biol. 2016 Feb 8;2016(1):6. eCollection 2016 Dec.

13.

[Re: All suicides are not due to treatment failure].

Jørstad RG, Bukholm IR.

Tidsskr Nor Laegeforen. 2015 Sep 22;135(17):1531. doi: 10.4045/tidsskr.15.0913. eCollection 2015 Sep 22. Norwegian. No abstract available.

14.

The epidermal growth factor receptor (EGFR / HER-1) gatekeeper mutation T790M is present in European patients with early breast cancer.

Bemanian V, Sauer T, Touma J, Lindstedt BA, Chen Y, Ødegård HP, Vetvik KM, Bukholm IR, Geisler J.

PLoS One. 2015 Aug 12;10(8):e0134398. doi: 10.1371/journal.pone.0134398. eCollection 2015.

15.

Ethnicity differences in breast cancer stage at the time of diagnosis in Norway.

Latif F, Helgeland J, Bukholm G, Bukholm IR.

Scand J Surg. 2015 Dec;104(4):248-53. doi: 10.1177/1457496914565420. Epub 2015 Feb 27.

PMID:
25724626
16.

High prevalence of human cytomegalovirus in brain metastases of patients with primary breast and colorectal cancers.

Taher C, Frisk G, Fuentes S, Religa P, Costa H, Assinger A, Vetvik KK, Bukholm IR, Yaiw KC, Smedby KE, Bäcklund M, Söderberg-Naucler C, Rahbar A.

Transl Oncol. 2014 Dec;7(6):732-40. doi: 10.1016/j.tranon.2014.09.008.

17.

The 5p12 breast cancer susceptibility locus affects MRPS30 expression in estrogen-receptor positive tumors.

Quigley DA, Fiorito E, Nord S, Van Loo P, Alnæs GG, Fleischer T, Tost J, Moen Vollan HK, Tramm T, Overgaard J, Bukholm IR, Hurtado A, Balmain A, Børresen-Dale AL, Kristensen V.

Mol Oncol. 2014 Mar;8(2):273-84. doi: 10.1016/j.molonc.2013.11.008. Epub 2013 Dec 3.

18.

Up-regulation of CLDN1 in gastric cancer is correlated with reduced survival.

Eftang LL, Esbensen Y, Tannæs TM, Blom GP, Bukholm IR, Bukholm G.

BMC Cancer. 2013 Dec 10;13:586. doi: 10.1186/1471-2407-13-586.

19.

Deregulation of cancer-related miRNAs is a common event in both benign and malignant human breast tumors.

Tahiri A, Leivonen SK, Lüders T, Steinfeld I, Ragle Aure M, Geisler J, Mäkelä R, Nord S, Riis ML, Yakhini Z, Kleivi Sahlberg K, Børresen-Dale AL, Perälä M, Bukholm IR, Kristensen VN.

Carcinogenesis. 2014 Jan;35(1):76-85. doi: 10.1093/carcin/bgt333. Epub 2013 Oct 8.

PMID:
24104550
20.

Gene expression profile analysis of t1 and t2 breast cancer reveals different activation pathways.

Riis ML, Zhao X, Kaveh F, Vollan HS, Nesbakken AJ, Solvang HK, Lüders T, Bukholm IR, Kristensen VN.

ISRN Oncol. 2013;2013:924971. doi: 10.1155/2013/924971. Epub 2013 Feb 28.

21.

Molecular profiles of pre- and postoperative breast cancer tumours reveal differentially expressed genes.

Riis ML, Lüders T, Markert EK, Haakensen VD, Nesbakken AJ, Kristensen VN, Bukholm IR.

ISRN Oncol. 2012;2012:450267. doi: 10.5402/2012/450267. Epub 2012 Nov 26.

22.

Processes of enhanced self-understanding during a counselling programme for parents of children with disabilities.

Haugstvedt KT, Graff-Iversen S, Bukholm IR, Haugli L, Hallberg U.

Scand J Caring Sci. 2013 Mar;27(1):108-16. doi: 10.1111/j.1471-6712.2012.01008.x. Epub 2012 May 24.

PMID:
22620983
23.

mRNA expression of adipocytokines and glucocorticoid-related genes are associated with downregulation of E-cadherin mRNA in colorectal adenocarcinomas.

Størkson RH, Aamodt R, Vetvik KK, Pietilainen K, Bukholm G, Jonsdottir K, Vollan HS, Sonerud T, Lüders T, Jacobsen MB, Bukholm IR.

Int J Colorectal Dis. 2012 Aug;27(8):1021-7. doi: 10.1007/s00384-012-1442-6. Epub 2012 Mar 14.

PMID:
22411584
24.

Interleukin-8 is the single most up-regulated gene in whole genome profiling of H. pylori exposed gastric epithelial cells.

Eftang LL, Esbensen Y, Tannæs TM, Bukholm IR, Bukholm G.

BMC Microbiol. 2012 Jan 17;12:9. doi: 10.1186/1471-2180-12-9.

25.

Overall survival after resection for colon cancer in a national cohort study was adversely affected by TNM stage, lymph node ratio, gender, and old age.

Storli KE, Søndenaa K, Bukholm IR, Nesvik I, Bru T, Furnes B, Hjelmeland B, Iversen KB, Eide GE.

Int J Colorectal Dis. 2011 Oct;26(10):1299-307. doi: 10.1007/s00384-011-1244-2. Epub 2011 May 12.

26.

The endothelin axis in the metastatic process of colon carcinoma.

Sørby LA, Kleiveland CR, Andersen SN, Bukholm IR, Jacobsen MB.

Anticancer Res. 2011 Mar;31(3):861-9.

PMID:
21498707
27.

Lymph node micrometastases and isolated tumor cells influence survival in stage I and II colon cancer.

Faerden AE, Sjo OH, Bukholm IR, Andersen SN, Svindland A, Nesbakken A, Bakka A.

Dis Colon Rectum. 2011 Feb;54(2):200-6. doi: 10.1007/DCR.0b013e3181fd4c7c.

PMID:
21228669
28.

Expression of BMI-1 and Mel-18 in breast tissue--a diagnostic marker in patients with breast cancer.

Riis ML, Lüders T, Nesbakken AJ, Vollan HS, Kristensen V, Bukholm IR.

BMC Cancer. 2010 Dec 16;10:686. doi: 10.1186/1471-2407-10-686.

29.

Evaluation of suitable reference genes for normalization of real-time reverse transcription PCR analysis in colon cancer.

Sørby LA, Andersen SN, Bukholm IR, Jacobsen MB.

J Exp Clin Cancer Res. 2010 Nov 8;29:144. doi: 10.1186/1756-9966-29-144.

30.

The Prognostic Impact of Protein Expression of E-Cadherin-Catenin Complexes Differs between Rectal and Colon Carcinoma.

Aamodt R, Bondi J, Andersen SN, Bakka A, Bukholm G, Bukholm IR.

Gastroenterol Res Pract. 2010;2010. pii: 616023. doi: 10.1155/2010/616023. Epub 2010 Aug 16.

31.

Differences in protein expression and gene amplification of cyclins between colon and rectal adenocarcinomas.

Aamodt R, Jonsdottir K, Andersen SN, Bondi J, Bukholm G, Bukholm IR.

Gastroenterol Res Pract. 2009;2009:285830. doi: 10.1155/2009/285830. Epub 2009 Dec 15.

32.

TP53 mutation status and gene expression profiles are powerful prognostic markers of breast cancer.

Langerød A, Zhao H, Borgan Ø, Nesland JM, Bukholm IR, Ikdahl T, Kåresen R, Børresen-Dale AL, Jeffrey SS.

Breast Cancer Res. 2007;9(3):R30.

33.
34.

Discovery and validation of breast cancer subtypes.

Kapp AV, Jeffrey SS, Langerød A, Børresen-Dale AL, Han W, Noh DY, Bukholm IR, Nicolau M, Brown PO, Tibshirani R.

BMC Genomics. 2006 Sep 11;7:231. Erratum in: BMC Genomics. 2007 Apr 13;8(1):101.

36.

An increase in the number of adhesion proteins with altered expression is associated with an increased risk of cancer death for colon carcinoma patients.

Bondi J, Bukholm G, Nesland JM, Bakka A, Bukholm IR.

Int J Colorectal Dis. 2006 Apr;21(3):231-7. Epub 2005 Jun 4.

PMID:
15937692
37.
38.
39.

Presence of isolated tumour cells in mesenteric lymph nodes predicts poor prognosis in patients with stage II colon cancer.

Bukholm IR, Bondi J, Wiik P, Nesland JM, Andersen SN, Bakka A, Bukholm G.

Eur J Surg Oncol. 2003 Dec;29(10):862-6.

PMID:
14624779
40.

Overexpression of cyclin A overrides the effect of p53 alterations in breast cancer patients with long follow-up time.

Bukholm IR, Husdal A, Nesland JM, Langerød A, Bukholm G.

Breast Cancer Res Treat. 2003 Jul;80(2):199-206.

PMID:
12908823
41.

Association between histology grade, expression of HsMCM2, and cyclin A in human invasive breast carcinomas.

Bukholm IR, Bukholm G, Holm R, Nesland JM.

J Clin Pathol. 2003 May;56(5):368-73.

42.

The TP53 codon 72 polymorphism may affect the function of TP53 mutations in breast carcinomas but not in colorectal carcinomas.

Langerød A, Bukholm IR, Bregård A, Lønning PE, Andersen TI, Rognum TO, Meling GI, Lothe RA, Børresen-Dale AL.

Cancer Epidemiol Biomarkers Prev. 2002 Dec;11(12):1684-8.

43.
44.

Coexpression of cyclin A and beta-catenin and survival in breast cancer patients.

Bukholm IR, Bukholm G, Nesland JM.

Int J Cancer. 2001 Oct 1;94(1):148-9. No abstract available.

45.

Supplemental Content

Loading ...
Support Center